LLY-284
Maka nyocha sayensị naanị, ọ bụghị maka ndị ọrịa.
Nkọwa ngwaahịa
Mkpado ngwaahịa
| Nha ngwugwu | Nnweta | Ọnụ ego (USD) |
| 0.1G | Dị na ngwaahịa | 350 |
| 0.5G | Dị na ngwaahịa | 750 |
| 1G | Dị na ngwaahịa | 910 |
Aha kemịkalụ:
7H-Pyrrolo [2,3-d] pyrimidin-4-amine, 7-[(5S) -5-C-phenyl-β-D-ribofuranosyl] -
Koodu Ọchịchọ:
O[C@H]1[C@H](N2C3C(=C(N=CN=3)N)C=C2)O[C@]([H])([C@@H](O) C2C=CC=CC=2)[C@H]1O
Koodu InChi:
InChi=1S/C17H18N4O4/c18-15-10-6-7-21(16(10)20-8-19-15)17-13(24)12(23)14(25-17)11(22) 9-4-2-1-3-5-9/h1-8,11-14,17,22-24H,(H2,18,19,20)/t11-,12-,13+,14+, 17+/m0/s1
Igodo InChi:
WWOOWAHTEXIWBO-CNUKPYSBSA-N
Okwu:
2226515-75-7;CAS:2226515-75-7;CAS:2226515-75-7;LLY-284
Solubility:
Nchekwa:
Nkọwa:
LLY-283 bụ ihe mgbochi dị irè nke PRMT5.
Ebumnuche: PRMT5
![3-chloro-2- (10-fluoro-8- (prop-1-yn-1-yl) -1,2,3,4,12,12a-hexahydro-6H-benzo[f] pyrazino[2,1] -c [1,4] oxazepin-9-yl) phenol](http://www.caerulumpharm.com/uploads/20240722105749.jpg)
![1H-Pyrazolo [3,4-d] pyrimidine, 6-chloro-1-[4-[1- (1-methylethyl) -4- (trifluoromethyl) -1H-imidazole-2-yl] phenyl] methyl] -](http://www.caerulumpharm.com/uploads/20240603134133.jpg)
![4H-1,3-Dioxolo [4,5-c] pyrrole-4-carboxylic acid, tetrahydro-2,2-dimethyl-6-oxo-, (3aS,4S,6aS)](http://www.caerulumpharm.com/uploads/20241023143839.jpg)
